Startup Description – Relay Technology Management identifies innovative IP from research and academic organizations and facilitates licensing to drug development firms. Relay maintains and fosters strong relationships with organizations along the drug development chain – researchers, biotech firms, tech transfer offices and more.
Who are the target clients? Academic Biomedical Researchers, Drug Developers, Foundations
So what? As a patent commodity brokerage firm, Relay has created a network of key players to manage the drug develop process. Scientific and business assessment of IP is accomplished by a team of Ph.D.s, MDs, and MD/MBAs. IP holders, academic institutions, and technology transfer offices are connected to the right drug development firms and biotech companies.
What does CI think is innovative? By focusing on the entire drug development chain rather than just one link, Relay is able to help interesting IP transition from ideas to revenue smoothly. Relay consults and handles the process and relationships so that the various parties can continue to focus on their specific strengths.